Pharmadrug Inc. (CSE:PHRX)
Canada · Delayed Price · Currency is CAD 0.0150
+0.0050 (50.00%)
At close: Feb 6, 2026
Pharmadrug Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.01M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 7.01K | -676.66K | -98.97% |
| Dec 31, 2020 | 683.67K | 73.10K | 11.97% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TILT Holdings | 128.37M |
| Ayurcann Holdings | 31.28M |
| Adastra Holdings | 16.86M |
| RAMM Pharma | 3.78M |
| Vencanna Ventures | 3.60M |
| Aion Therapeutic | 1.47M |
| Ovation Science | 63.82K |
| Genix Pharmaceuticals | 68.00 |